PubMed Health⌕ Search

Biomedical subjects

B V Popov

Publications and source records attributed to B V Popov.

9 recordsLinked to original sources
PubMed1988

[Differentiation and a change in the sensitivity to antibrain serum of circulating colony-forming units under the action of thymic factors].

The rabbit anti-mouse brain serum (RAMBS) that interacts with SC-1 marked cells, rather than with thymocytes and bone marrow cells, inhibits most of the blood and bone marrow colony-forming unit (CFU) population. A commercial thymus preparation thymalin increases the granulocytopoietic activity of the circulating CFU and decreases their sensitivity to RAMBS in thymectomized and normal animals. Differentiation of circulating CFU remains unchanged in thymalin-treated mice after RAMBS administration, while CFU erythroid activity of nontreated animals is lowered. The revealed changes in the CFU differentiation and sensitivity to RAMBS confirm the assumption that SC-1 antigen may mark Thy-1 lymphocytes of their microenvironment, rather than CFU.

Adjuvants, Immunologic↗
PubMed1986

[Colony-forming units of the bone marrow and spleen of immunodeficient mice after stimulation of the cells with thymalin].

It has been previously demonstrated by the authors that histological characteristics of colony-forming units (CFUs) in normal mice prove a certain shift in their differentiation in erythroid direction comparing to the bone marrow CFUs. Thymectomy of mature animals is accompanied with weakening growth of granular colonies at cloning of the bone marrow CFUs and with loss of stability in direction of splenic CFUs differentiation. Polypeptide preparation of the thymus--thymalin stimulates growth of the granulocytic colonies from the splenic CFUs in thymectomized mice both in in vivo and in vitro experiments. Differentiation of the bone marrow CFUs is normalized under the effect of thymalin in in vivo experiment only. The data obtained confirm the suggestion made by R. V. Petrov on existence of T-cell clone, enhancing CFUs differentiation in granulocytic direction. Activation of this clone in the spleen is revealed at thymectomy and stimulation of the cells with thymalin both in in vivo and in vitro experiments. Thus, affirmations are obtained on differences of clonic T-cell regulation of the CFUs differentiation in the bone marrow and in the spleen.

Animals↗
PubMed1985

[Thymus-dependent suppression of erythroid colony formation induced by concanavalin A in the cloning of pluripotent hematopoietic stem cells of the spleen].

The injection of the polyclonal activator of T-cells--concanavalin A--to normal mice is followed by a considerable decrease both in the erythroid colony-formation at the cloning of spleen CFUs, and in the number of T-cells and their helper activity in the same spleen suspensions. The suppression of erythroid colony-formation may be passively transferred by using spleen cells from mice treated with concanavalin A and irradiated lethally. Thymectomy of adult mice prevents from suppression of erythroid colony-formation induced by concanavalin A. These results suggest that the T-cells may suppress erythroid differentiation of hemopoietic stem cells.

Animals↗
PubMed1985

[Differentiation characteristics of circulating and bone marrow hematopoietic stem cells and the effect of thymus factors].

Circulating hemopoietic stem cells (HSC) considerably differ from bone marrow HSC in active erythroid differentiation. After thymectomy of adult animals the number and differentiation of blood HSC remain unchanged, whereas during the cloning of bone marrow cells, a decrease in the number of granulocytic colonies is revealed. In in-vitro experiments, thymalin does not influence the number or differentiation of circulating HSC. On the contrary, in experiments made in vivo, it dramatically lowers erythroid specialization of blood HSC in thymectomized and sham-operated mice, which is followed by the diminution of the total number of circulating HSC. Differentiation of thymectomized mice bone marrow stem cells is completely normalized after thymalin injection. Sham-operated and thymectomized animals' HSC stimulated by thymalin injection become similar to bone marrow cells of normal mice as regards the trend of differentiation. Thymalin injection is likely to change the bone marrow HSC differentiation profile, thereby preventing the release of the cells with erythroid-oriented differentiation from the bone marrow to blood. The influence of thymalin on HSC is mediated by the environmental component which is present in the bone marrow and absent from the peripheral blood.

Adjuvants, Immunologic↗